Urinary concentration test with desmopressin.
作者信息
Delin K, Aurell M, Ewald J
出版信息
Br Med J. 1978 Mar 25;1(6115):757-8. doi: 10.1136/bmj.1.6115.757.
Abstract
摘要
相似文献
1
Urinary concentration test with desmopressin.去氨加压素的尿浓缩试验。
Br Med J. 1978 Mar 25;1(6115):757-8. doi: 10.1136/bmj.1.6115.757.
2
Desmopressin urine concentration test.去氨加压素尿液浓缩试验。
Br Med J. 1978 Jan 7;1(6104):24. doi: 10.1136/bmj.1.6104.24.
3
Age and urine concentration after desmopressin.去氨加压素后的年龄与尿液浓缩情况
Br Med J. 1978 Apr 22;1(6119):1054-5. doi: 10.1136/bmj.1.6119.1054-c.
4
Desamino arginine vasopressin (DDAVP) as a diagnostic agent.去氨基精氨酸血管加压素（DDAVP）作为一种诊断剂。
N Z Med J. 1977 Nov 23;86(600):472-3.
5
6
7
Vasopressin secretion in response to osmotic stimulation and effects of desmopressin on urinary concentrating capacity in dogs with pyometra.
Am J Vet Res. 2004 Apr;65(4):404-8. doi: 10.2460/ajvr.2004.65.404.
8
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.血管加压素、 copeptin 和肾功能正常的常染色体显性多囊肾病患者的肾浓缩能力。
Clin J Am Soc Nephrol. 2012 Jun;7(6):906-13. doi: 10.2215/CJN.11311111. Epub 2012 Apr 19.
9
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.1-去氨基-8-D-精氨酸加压素（DDAVP）对人体的抗利尿作用。
Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):199-209.
10
[A short-term test using DDAVP for determination of the renal concentration capacity (author's transl)].使用去氨加压素进行肾浓缩功能测定的短期试验（作者译）
Monatsschr Kinderheilkd (1902). 1977 Mar;125(3):165-7.
引用本文的文献
1
Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms.调控信号转导通路的环肽：从原核生物到多细胞生物。
Curr Top Med Chem. 2018;18(7):625-644. doi: 10.2174/1568026618666180518090705.
2
Arginine vasopressin in health and disease.
Br Med J. 1978 Jul 22;2(6132):232-3. doi: 10.1136/bmj.2.6132.232.
3
Assessment of renal concentrating ability.肾浓缩能力评估。
Br Med J. 1979 Mar 31;1(6167):888. doi: 10.1136/bmj.1.6167.888-c.
4
Assessment of renal concentrating ability.肾浓缩能力评估
Br Med J. 1979 Feb 3;1(6159):304-5. doi: 10.1136/bmj.1.6159.304.
本文引用的文献
1
Vasopressin tannate in oil and the urine concentration test.油制鞣酸加压素与尿液浓缩试验
Lancet. 1956 Jun 30;270(6931):1037-8. doi: 10.1016/s0140-6736(56)90801-7.
2
Urine concentration after fluid deprivation or pitressin tannate in oil.禁水或油剂鞣酸加压素后的尿浓缩功能。
Br Med J. 1956 Feb 4;1(4961):271-4. doi: 10.1136/bmj.1.4961.271.
3
Effects of DDAVP, a synthetic analogue of vasopressin, in patients with cranial diabetes insipidus.
Acta Med Scand. 1972 Jul-Aug;192(1-2):21-7. doi: 10.1111/j.0954-6820.1972.tb04772.x.
4
DDAVP test for estimation of renal concentrating capacity in infants and children.用于评估婴幼儿肾脏浓缩功能的去氨加压素试验。
Arch Dis Child. 1974 Aug;49(8):654-9. doi: 10.1136/adc.49.8.654.
5
Urine concentrating capacity in women: the results of a screening method in a population study.女性的尿液浓缩能力：一项人群研究中筛查方法的结果
Clin Nephrol. 1976 Dec;6(6):518-22.
Zotero 插件